ArticleMaterials today. Bio2026

A versatile nanoplatform for enhancing the therapeutic efficacy against low-immunogenic TNBC by inducing immunogenic cell death and MHC-I upregulation.

Shanlingzi Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.